Stay updated on TERN-501 and TERN-101 in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.

Latest updates to the TERN-501 and TERN-101 in NASH Clinical Trial page
- Check3 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating access is blocked and the prior content is no longer accessible.SummaryDifference18%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a newer internal version of the page and not altering study details or how the study information is presented.SummaryDifference0.0%

- Check45 days agoChange DetectedThe sponsor line now specifies the full corporate entity providing information, and the revision label was updated to v3.6.5, reflecting a new page version.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page, indicating a version update to the study detail page. The study information and layout appear unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page updates its liver disease terminology by swapping Fatty Liver Disease for Steatotic Liver Disease in its glossary. This reflects a terminology alignment in the page’s contextual descriptions.SummaryDifference0.0%

- Check81 days agoChange DetectedThe revision label on the page was updated to v3.6.3, replacing the previous v3.6.2, indicating a backend/template update rather than a change to study data.SummaryDifference0.0%

Stay in the know with updates to TERN-501 and TERN-101 in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-501 and TERN-101 in NASH Clinical Trial page.